UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| 1 |
Amazon
AMZN
|
+$391M |
| 2 |
Coca-Cola
KO
|
+$238M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$225M |
| 4 |
Mondelez International
MDLZ
|
+$194M |
| 5 |
Apple
AAPL
|
+$190M |
Top Sells
| 1 |
TAL Education Group
TAL
|
+$229M |
| 2 |
Walmart
WMT
|
+$175M |
| 3 |
Comcast
CMCSA
|
+$99.1M |
| 4 |
Yum! Brands
YUM
|
+$93.8M |
| 5 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$87.1M |
Sector Composition
| 1 | Technology | 21.48% |
| 2 | Healthcare | 14.46% |
| 3 | Consumer Discretionary | 12.94% |
| 4 | Financials | 12.31% |
| 5 | Communication Services | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
UroGen Pharma
URGN
$884M
| $389K | ﹤0.01% |
21,801
+5,400
| +33% | +$96.3K |
|
2027
Alaunos Therapeutics
TCRT
$4.83M
| $388K | ﹤0.01% |
1,056
+127
| +14% | +$46.7K |
|
2028
Wipro
WIT
$29.4B
| $388K | ﹤0.01% |
250,442
| – | – |
|
2029
Catalyst Pharmaceutical
CPRX
$2.42B
| $387K | ﹤0.01% |
100,643
+6,881
| +7% | +$26.5K |
|
|
GOOD
2030
Gladstone Commercial Corp
GOOD
$598M
| $385K | ﹤0.01% |
26,833
+2,260
| +9% | +$32.5K |
|
|
CBPO
2031
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $385K | ﹤0.01% |
3,570
| – | – |
|
|
PFC
2032
DELISTED
Premier Financial Corp. Common Stock
PFC
| $385K | ﹤0.01% |
26,127
+17,892
| +217% | +$264K |
|
2033
Weis Markets
WMK
$1.73B
| $384K | ﹤0.01% |
9,211
-1,422
| -13% | -$59.2K |
|
|
GTS
2034
DELISTED
Triple-S Management Corporation
GTS
| $383K | ﹤0.01% |
27,195
-6,830
| -20% | -$96.3K |
|
2035
Customers Bancorp
CUBI
$2.35B
| $381K | ﹤0.01% |
34,819
+936
| +3% | +$10.2K |
|
2036
MarineMax
HZO
$545M
| $380K | ﹤0.01% |
36,437
+22,049
| +153% | +$230K |
|
2037
ArcBest
ARCB
$1.61B
| $378K | ﹤0.01% |
21,574
-8,150
| -27% | -$143K |
|
2038
Archrock
AROC
$4.35B
| $378K | ﹤0.01% |
100,477
-10,798
| -10% | -$40.6K |
|
|
VRS
2039
DELISTED
Verso Corporation
VRS
| $377K | ﹤0.01% |
33,410
-641
| -2% | -$7.23K |
|
|
GMRE
2040
Global Medical REIT
GMRE
$511M
| $377K | ﹤0.01% |
37,239
+16,439
| +79% | +$166K |
|
2041
Heritage Insurance Holdings
HRTG
$683M
| $376K | ﹤0.01% |
35,098
-3,499
| -9% | -$37.5K |
|
|
ATNX
2042
DELISTED
Athenex, Inc. Common Stock
ATNX
| $376K | ﹤0.01% |
2,426
+324
| +15% | +$50.2K |
|
|
HNGR
2043
DELISTED
Hanger Inc.
HNGR
| $375K | ﹤0.01% |
24,096
-5,624
| -19% | -$87.6K |
|
2044
Ethan Allen Interiors
ETD
$745M
| $373K | ﹤0.01% |
36,514
+4,915
| +16% | +$50.2K |
|
2045
Evolent Health
EVH
$1.07B
| $373K | ﹤0.01% |
68,632
-6,176
| -8% | -$33.5K |
|
2046
Thermon Group Holdings
THR
$826M
| $371K | ﹤0.01% |
24,620
-1,779
| -7% | -$26.8K |
|
2047
Ingles Markets
IMKTA
$1.29B
| $370K | ﹤0.01% |
10,239
+2,000
| +24% | +$72.3K |
|
2048
The Bancorp
TBBK
$3.5B
| $367K | ﹤0.01% |
60,524
-7,815
| -11% | -$47.4K |
|
2049
Banc of California
BANC
$2.65B
| $366K | ﹤0.01% |
45,716
-6,515
| -12% | -$52.1K |
|
2050
Community Health Systems
CYH
$409M
| $365K | ﹤0.01% |
109,338
+31,906
| +41% | +$107K |
|